서린바이오, 지난해 배당성향 117.8%…주주환원 정책 유지

Seorin Bio is aggressively implementing a shareholder return policy with a dividend payout ratio exceeding 100%, aligning with the 'Corporate Value-up' trend in the Korean market. By integrating AI analysis services and expanding its business portfolio, the company aims to secure sustainable growth drivers while maintaining its commitment to high investor payouts.